Late intraocular pressure rise following intravitreal triamcinolone injection.
Most ophthalmologists are aware of the risk of elevated intraocular pressure developing 1 or 2 months after an intravitreal injection of triamcinolone. However, the two cases reported here demonstrate that such a rise can occur significantly later than this. All patients who have had intravitreal steroid injection should therefore have prolonged intraocular pressure monitoring.
Williams
Christopher P R
CP
Konstantopoulos
Aristides
A
Rowley
Steven A
SA
Luff
Andrew J
AJ
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000139:chemically induced* / Q000188:drug therapy; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014822:Vitreous Body
D000959:Antihypertensive Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide